Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Working Capital to Net Assets Ratio
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A working capital to net assets ratio. Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Working Capital to Net Assets ratio of 14.9% as of March 2026. Working capital of CN¥333.52 Million (current assets of CN¥2.98 Billion minus current liabilities of CN¥2.65 Billion) is measured against net assets of CN¥2.24 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Working capital to net assets ratio of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025. This chart shows how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 14.9%, reflecting working capital of CN¥333.52 Million against net assets of CN¥2.24 Billion CNY. See 301408 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Working Capital to Net Assets Ratio by Year (2021–2025)
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Anhui Huaren Health Pharmaceutical Co. L assets under control.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.5% | CN¥227.37 Million | CN¥2.16 Billion | CN¥2.91 Billion | CN¥2.69 Billion | ▼ -9.8 pp |
| 2024 | 20.3% | CN¥418.84 Million | CN¥2.06 Billion | CN¥2.60 Billion | CN¥2.18 Billion | ▼ -23.3 pp |
| 2023 | 43.6% | CN¥862.52 Million | CN¥1.98 Billion | CN¥2.83 Billion | CN¥1.96 Billion | ▲ +7.9 pp |
| 2022 | 35.7% | CN¥338.42 Million | CN¥947.01 Million | CN¥1.70 Billion | CN¥1.36 Billion | ▲ +6.4 pp |
| 2021 | 29.4% | CN¥230.65 Million | CN¥785.05 Million | CN¥1.11 Billion | CN¥882.64 Million | — |